Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused
Recruiting now
This study looks at how certain cancer immunotherapies (anti-PD-1 drugs) might affect bone strength. Researchers will measure bone density and blood markers in 25 adults receiving these treatments for cancers like melanoma, lung, or breast cancer. The goal is to understand if the…
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC